Job Description:
NewAmsterdam is an innovative biotech company with the experience and expertise to deliver across its ambitious clinical, regulatory, and commercial goals. Our robust scientific approach focuses on advancing a new era of life-saving treatments for lipid-related diseases. Our vision is that people at risk for heart disease can take control of their health and live longer, fuller lives. Our team is led by a world-class team of industry veterans and key opinion leaders, including some of the world’s preeminent cardiometabolic experts and we foster a passionate, supportive culture that is backed by a high level of integrity and inclusivity.
Position Overview: The Associate Director/ Director, Financial Planning and Analysis is responsible for the financial management for a business unit within NAP. This role will manage large budgets and ensure the financial health and efficiency of our processes while preparing for commercial launch.
Key Responsibilities:
FP&A
Oversee the financial planning, analysis, and reporting.
Manage large budgets, ensuring cost-effective operations and maximizing financial performance.
Develop and implement financial strategies to support manufacturing objectives and company growth.
Support to Business Leaders:
Partner with Business Leaders, CFO and CAO to provide financial insights and support decision-making.
Collaborate on strategic initiatives and long-term planning for the function
Prepare and present financial reports, forecasts, and analyses to the executive leadership team.
Accounting and Compliance:
Ensure accurate and timely accounting for all transactions.
Maintain compliance with all relevant financial regulations and industry standards.
Implement and oversee internal controls to safeguard company assets and ensure financial integrity.
Forecasting and Budgeting:
Manage the development of annual budgets, quarterly forecasts, and long-term financial plans.
Monitor financial performance against budgets and forecasts, identifying variances and recommending corrective actions.
Provide detailed financial modelling and scenario analysis to support strategic decision-making.
Operational Efficiency:
Analyze business processes and workflows to identify opportunities for cost reduction and efficiency improvements.
Partner with leaders to implement best practices and drive operational excellence.
Monitor key performance indicators (KPIs) and metrics to assess financial and operational performance.
Culture
Foster a culture of continuous improvement, professional development, and collaboration.
Ensure effective communication and alignment between finance and business unit.
Qualifications:
Bachelor's degree in Finance, Accounting, or a related field; MBA or CPA preferred.
Minimum of 6-8 years of finance experience, with at least 3 years in a leadership role within biotechnology or pharmaceutical manufacturing.
Experience managing large budgets and driving financial performance.
Knowledge and understanding of the biotechnology industry, and forecasting in late-stage clinical trials, commercial launch experience preferred.
Experience with cost accounting, and financial analysis.
Ability to work on cross-functional basis to ensure achievement of functional goals and alignment with corporate objectives.
Exceptional analytical, strategic thinking, and problem-solving skills.
Excellent communication and interpersonal skills, with the ability to influence and collaborate at all levels.
Proficiency in financial software and ERP systems.
Salary and Benefits:
We offer a competitive base salary, annual bonus, and long-term incentives. In addition, we provide a comprehensive benefits package, including health insurance, dental and vision coverage, term life and disability coverage, and retirement plans.
NewAmsterdam Pharma is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information, or any other basis protected by federal, state or local law.